BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19816699)

  • 1. Assessment of Elastic Laminal Invasion Contributes to an Objective pT3 Subclassification in Colon Cancer.
    Kojima M; Yokota M; Yanagisawa N; Kitamura S; Amemiya K; Kawano S; Tsukada Y; Sakuyama N; Nagayasu K; Hashimoto T; Nakashima K; Jiang K; Kanemitsu Y; Fujita F; Akiba J; Notohara K; Itakura J; Sekine S; Sakashita S; Sakamoto N; Ishikawa S; Nakanishi Y; Yao T; Liang WY; Lauwers GY; Ito M; Sakamoto K; Ishii G; Ochiai A
    Am J Surg Pathol; 2023 Oct; 47(10):1122-1133. PubMed ID: 37395605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic scoring system based on indicators reflecting the tumor glandular differentiation and microenvironment for patients with colorectal cancer.
    Kobayashi T; Ishida M; Miki H; Yamamoto N; Harino T; Yagyu T; Hori S; Hatta M; Hashimoto Y; Kotsuka M; Yamasaki M; Inoue K; Hirose Y; Sekimoto M
    Sci Rep; 2024 Jun; 14(1):14188. PubMed ID: 38902294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver, intraobserver, and interlaboratory variability in reporting pT4a colon cancer.
    Klaver CEL; Bulkmans N; Drillenburg P; Grabsch HI; van Grieken NCT; Karrenbeld A; Koens L; van Lijnschoten I; Meijer J; Nagtegaal ID; Sagaert X; Seldenrijk K; van Velthuysen MF; Bruggink AH; Tanis PJ; Snaebjornsson P
    Virchows Arch; 2020 Feb; 476(2):219-230. PubMed ID: 31616981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of immunohistochemistry pan-cytokeratin and Victoria blue double staining in the assessment of pT3 and pT4a colorectal cancer staging].
    Xie LW; Wang J; Bu P
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1034-1036. PubMed ID: 37805397
    [No Abstract]   [Full Text] [Related]  

  • 5. The measured distance between tumor cells and the peritoneal surface predicts the risk of peritoneal metastases and offers an objective means to differentiate between pT3 and pT4a colon cancer.
    Zwanenburg ES; Wisselink DD; Klaver CEL; van der Bilt JDW; Tanis PJ; Snaebjornsson P;
    Mod Pathol; 2022 Dec; 35(12):1991-2001. PubMed ID: 36123540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer.
    Macchi L; Bao QR; Albertoni L; Fassan M; Chiminazzo V; Scarpa M; Spolverato G; Pucciarelli S
    Int J Clin Oncol; 2022 Sep; 27(9):1428-1438. PubMed ID: 35716324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance and survival implications of preoperative subclassification of T3 rectal cancers by depth of mesorectal invasion using a 5-mm cut-off point with endorectal ultrasound and magnetic resonance imaging.
    García Botello S; Martí Fernández R; Cozar Lozano C; Campos Salher S; Martín Arévalo J; Moro Valdezate D; Pla Martí V; Espí Macías A
    Quant Imaging Med Surg; 2022 Apr; 12(4):2356-2367. PubMed ID: 35371947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Long-Term Survival Outcomes of T4a and T4b Colorectal Cancer.
    Lim JH; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Front Oncol; 2021; 11():780684. PubMed ID: 35070985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort.
    Osterman E; Mezheyeuski A; Sjöblom T; Glimelius B
    Ann Surg Oncol; 2020 Apr; 27(4):1036-1045. PubMed ID: 31893351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Should Imaging Direct/Orient Management of Rectal Cancer?
    Bhoday J; Balyasnikova S; Wale A; Brown G
    Clin Colon Rectal Surg; 2017 Nov; 30(5):297-312. PubMed ID: 29184465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer.
    Akagi Y; Shirouzu K; Kinugasa T
    J Surg Oncol; 2013 Nov; 108(6):358-63. PubMed ID: 23970396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy.
    Akagi Y; Shirouzu K; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K
    Exp Ther Med; 2013 Mar; 5(3):661-666. PubMed ID: 23407463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has the new TNM classification for colorectal cancer improved care?
    Nagtegaal ID; Quirke P; Schmoll HJ
    Nat Rev Clin Oncol; 2011 Oct; 9(2):119-23. PubMed ID: 22009076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer.
    Pollheimer MJ; Kornprat P; Pollheimer VS; Lindtner RA; Schlemmer A; Rehak P; Langner C
    Int J Colorectal Dis; 2010 Feb; 25(2):187-96. PubMed ID: 19816699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
    Roscigno M; Cha EK; Rink M; Seitz C; Novara G; Chromecki TF; Fritsche HM; Matsumoto K; Walton TJ; Carballido J; Filippo Da Pozzo L; Bertini R; Ficarra V; Otto W; Karakiewicz PI; Pycha A; Fajkovic H; Naspro R; Scherr DS; Montorsi F; Shariat SF
    BJU Int; 2012 Sep; 110(5):674-81. PubMed ID: 22348322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic inhomogeneity in pT3 rectal carcinomas.
    Merkel S; Mansmann U; Siassi M; Papadopoulos T; Hohenberger W; Hermanek P
    Int J Colorectal Dis; 2001 Sep; 16(5):298-304. PubMed ID: 11686527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Paner GP; Montironi R; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological reporting of pT4 tumour stage in colorectal carcinomas: dotting the 'i's and crossing the 't's.
    Swamy R
    J Clin Pathol; 2010 Feb; 63(2):110-5. PubMed ID: 20154030
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.